Jeffrey W. Jacobs - 03 Aug 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
Issuer symbol
ARDX
Transactions as of
03 Aug 2021
Net transactions value
-$3,805
Form type
4
Filing time
05 Aug 2021, 17:00:54 UTC
Previous filing
17 Jun 2021
Next filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Options Exercise $5,400 +10,000 +8.1% $0.5400* 134,051 03 Aug 2021 Direct
transaction ARDX Common Stock Tax liability $9,205 -5,613 -4.2% $1.64 128,438 03 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Options Exercise $0 -10,000 -100% $0.000000* 0 03 Aug 2021 Common Stock 10,000 $0.5400 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were granted in August 2011 and set to expire on August 11, 2021.
F2 Fully exercisable.